Cargando…

Myelofibrosis-Related Arthritis Successfully Treated with Hydroxyurea

A 62-year-old woman suffering from one-year lasting, nonerosive peripheral arthritides with general health impairment and high acute-phase reactant levels was admitted to rheumatology department. The patient had suffered from chronic polyarthralgia and a thrombocytosis had been discovered 9 years be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guillot, Xavier, Moldovan, Marius, Vidon, Claire, Wendling, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003769/ https://www.ncbi.nlm.nih.gov/pubmed/24818035 http://dx.doi.org/10.1155/2014/869743

Ejemplares similares

Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea
por: Pacilli, Annalisa, et al.
Publicado: (2018)

Successful Control of Acute Myelofibrosis with Lenalidomide
por: Vassilopoulos, G., et al.
Publicado: (2010)

Dysregulated Serum IL-23 and SIRT1 Activity in Peripheral Blood Mononuclear Cells of Patients with Rheumatoid Arthritis
por: Wendling, Daniel, et al.
Publicado: (2015)

Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis
por: Pugliese, Novella, et al.
Publicado: (2019)

Successful treatment of hydroxyurea-associated panniculitis and vasculitis with low-dose methotrexate
por: Mattessich, Sarah, et al.
Publicado: (2017)

Primary Myelofibrosis-Related Renal Disorders Treated with a Janus Kinase Inhibitor
por: Asou, Mea, et al.
Publicado: (2021)

Pure Erythroid Leukemia in a Sickle Cell Patient Treated with Hydroxyurea
por: Yadav, Dhiraj Kumar, et al.
Publicado: (2020)

Successful Management of Hydroxyurea-induced Leg Ulcers in Essential Thrombocythemia: Report of 3 Cases
por: Rahal, Jihane Abou, et al.
Publicado: (2013)

Hydroxyurea Induced Perimalleolar Ulcers
por: Saravu, Kavitha, et al.
Publicado: (2006)

Polymyalgia Rheumatica Revealing a Lymphoma: A Two-Case Report
por: Verhoeven, Frank, et al.
Publicado: (2016)

Pulmonary cryptococcosis in a ruxolitinib-treated patient with primary myelofibrosis
por: Hirano, Anna, et al.
Publicado: (2017)

Acute variceal bleeding in a patient with idiopathic myelofibrosis successfully treated with endoscopic variceal band ligation and chemotherapy: a case report
por: Tamaki, Kumiko, et al.
Publicado: (2010)

Hydroxyurea and colonic ulcers: a case report
por: Boonyawat, Kochawan, et al.
Publicado: (2014)

Utility of hydroxyurea in mast cell activation syndrome
por: Afrin, Lawrence B
Publicado: (2013)

Case Report of Myelodysplastic Syndrome in a Sickle-Cell Disease Patient Treated with Hydroxyurea and Literature Review
por: Flevari, Pagona, et al.
Publicado: (2022)

Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis
por: Tsutsui, Miyuki, et al.
Publicado: (2019)

Use of ropeginterferon in inducing graft versus myelofibrosis effect in post‐transplant myelofibrosis relapse
por: Srivastava, Barnali, et al.
Publicado: (2023)

Long-Term Hematologic Improvement in a Patient With Cytopenic Myelofibrosis Treated With Pacritinib
por: Yacoub, Abdulraheem, et al.
Publicado: (2023)

Hydroxyurea Associated Cutaneous Lesions: A Case Report
por: Simeonovski, Viktor, et al.
Publicado: (2018)

Hydroxyurea-Induced Pneumopathy in a Patient With Myeloproliferative Syndrome
por: Galván, Oriol Plans, et al.
Publicado: (2018)

Leukoreduction and hydroxyurea in malignant pertussis: A case series
por: Aldairi, Nedaa, et al.
Publicado: (2020)

Hydroxyurea associated ileocecal valve ulcer: evidence for causality
por: Jayaraman, Thevaraajan, et al.
Publicado: (2021)

Chronic Lymphocytic Leukemia and Myelofibrosis
por: Darawshy, Fares, et al.
Publicado: (2018)

Blue Lunula Related with Hydroxyurea
por: Üsküdar Teke, Hava, et al.
Publicado: (2013)

The impact of ruxolitinib treatment on inflammation-mediated comorbidities in myelofibrosis and related neoplasms
por: Bjørn, Mads Emil, et al.
Publicado: (2015)

Ashy dermatosis-like hyperpigmentation in a patient taking hydroxyurea
por: Li, Stephen, et al.
Publicado: (2020)

Simultaneous hepatosplenic T-cell lymphoma and myelofibrosis
por: Gabali, Ali M, et al.
Publicado: (2014)

Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism
por: Rajan, Remya, et al.
Publicado: (2020)

Myelofibrosis and Portal Hypertension: The Case for Primary Variceal Screening
por: Sherman, Marc Samuel, et al.
Publicado: (2020)

Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis
por: Cerchione, Claudio, et al.
Publicado: (2017)

S212: A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF JAKTINIB VERSUS HYDROXYUREA IN PATIENTS WITH INTERMEDIATE-2 OR HIGH RISK MYELOFIBROSIS
por: Zhang, Yi, et al.
Publicado: (2023)

Yersinia enterocolitica Prosthetic Joint Septic Arthritis Successfully Treated with Ceftriaxone
por: Abdullah, Hafez M., et al.
Publicado: (2021)

Hydroxyurea-induced cutaneous squamous cell carcinoma: A case report
por: Xu, Yan, et al.
Publicado: (2019)

The Use of Hydroxyurea in the Treatment of COVID-19
por: Foster, Melissa Robin Bowman, et al.
Publicado: (2021)

Favorable COVID‐19 course despite significant comorbidities in a ruxolitinib‐treated patient with primary myelofibrosis
por: Koschmieder, Steffen, et al.
Publicado: (2020)

Response to pegylated interferon in a COVID‐19–positive elderly woman with primary myelofibrosis treated with ruxolitinib
por: Frankel, Arthur E., et al.
Publicado: (2021)

Dermatomyositis Associated with Myelofibrosis following Polycythemia Vera
por: Fei, Naomi, et al.
Publicado: (2017)

Recalcitrant annular pustular psoriasis associated with psoriatic arthritis successfully treated with secukinumab
por: Herrero-Moyano, María, et al.
Publicado: (2018)

Laser Photobiomodulation for a Complex Patient with Severe Hydroxyurea-Induced Oral Ulcerations
por: Cabras, Marco, et al.
Publicado: (2016)

Recurrent Subcutaneous Sweet's Disease in a Myelofibrosis Patient Treated with Ruxolitinib before Allogeneic Stem Cell Transplantation
por: Sakoda, Teppei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_haiqk79ovs8eh9apij7qf8o824